Article on improving viral vector production in GEN
GEN recently interviewed our Business Development Director, Dr. Natalia Elizalde, with whom they spoke about improving the production of lentiviral vectors, vectors that VIVEbiotech develops and manufactures.
Genetic Engineering & Biotechnology News (GEN) was the first publication in this field. GEN provides exclusive reporting, insight, and analysis across the life sciences, from its five foundational pillars of Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing to a new, expanded focus on the emerging areas of Cancer Research, Infectious Diseases, and Artificial Intelligence.
To read the article resulting from the interview, click here.